Gene · 1660
Papers2,696
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,696
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing. | J Am Chem Soc | 2023 | 37733759 | PubTator, text mining | PubMed |
| Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity. | Cancer Res Commun | 2023 | 37732905 | PubTator, text mining | PubMed |
| An updated database of virus circular RNAs provides new insights into the biogenesis mechanism of the molecule. | Emerg Microbes Infect | 2023 | 37725485 | PubTator, text mining | PubMed |
| Nuclear epidermal growth factor receptor as a therapeutic target. | Explor Target Antitumor Ther | 2023 | 37720348 | PubTator, text mining | PubMed |
| OTUD5 limits replication fork instability by organizing chromatin remodelers. | Nucleic Acids Res | 2023 | 37713620 | PubTator, text mining | PubMed |
| Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma. | Int J Biol Sci | 2023 | 37705753 | PubTator, text mining | PubMed |
| RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cells. | Nucleic Acids Res | 2023 | 37697435 | PubTator, text mining | PubMed |
| C-IGF1R encoded by cIGF1R acts as a molecular switch to restrict mitophagy of drug-tolerant persister tumour cells in non-small cell lung cancer. | Cell Death Differ | 2023 | 37689814 | PubTator, text mining | PubMed |
| Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges. | Int J Mol Sci | 2023 | 37686149 | PubTator, text mining | PubMed |
| N6 -methyladenosine-modified circFUT8 competitively interacts with YTHDF2 and miR-186-5p to stabilize FUT8 mRNA to promote malignant progression in lung adenocarcinoma. | Thorac Cancer | 2023 | 37669906 | PubTator, text mining | PubMed |
| Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma. | Sci Rep | 2023 | 37658148 | PubTator, text mining | PubMed |
| LGP2 directly interacts with flavivirus NS5 RNA-dependent RNA polymerase and downregulates its pre-elongation activities. | PLoS Pathog | 2023 | 37656756 | PubTator, text mining | PubMed |
| Development of assays to support identification and characterization of modulators of DExH-box helicase DHX9. | SLAS Discov | 2023 | 37625785 | PubTator, text mining | PubMed |
| Circular RNAs Variously Participate in Coronary Atherogenesis. | Curr Issues Mol Biol | 2023 | 37623241 | PubTator, text mining | PubMed |
| RNAPII-dependent ATM signaling at collisions with replication forks. | Nat Commun | 2023 | 37620345 | PubTator, text mining | PubMed |
| TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation. | Nat Commun | 2023 | 37607907 | PubTator, text mining | PubMed |
| Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. | J Immunother Cancer | 2023 | 37607770 | PubTator, text mining | PubMed |
| Correction: Long noncoding RNA SH3PXD2A-AS1 promotes NSCLC proliferation and accelerates cell cycle progression by interacting with DHX9. | Cell Death Discov | 2023 | 37604866 | PubTator, text mining | PubMed |
| The circRNA circVAMP3 restricts influenza A virus replication by interfering with NP and NS1 proteins. | PLoS Pathog | 2023 | 37603540 | PubTator, text mining | PubMed |
| Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity. | Aging (Albany NY) | 2023 | 37602882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1660/papers?page=13